Details for Patent: 12,728,138
Which drugs does patent 12,728,138 protect, and when does it expire?
Patent 12,728,138 protects POKONZA and POTASSIUM CHLORIDE and is included in one NDA.
Drugs Protected by US Patent 12,728,138
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | POKONZA | potassium chloride | SOLUTION;ORAL | 206814-003 | Nov 25, 2025 | RX | Yes | No | 12,728,138 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Genus Lifesciences | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 206814-001 | Dec 22, 2014 | AA | RX | Yes | No | 12,728,138 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Genus Lifesciences | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 206814-002 | Dec 22, 2014 | AA | RX | Yes | Yes | 12,728,138 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
